Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
<Observation xmlns="http://hl7.org/fhir">
<id value="MorphologyObservationExample"/>
<meta>
<profile
value="https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-morphology-observation"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Observation MorphologyObservationExample</b></p><a name="MorphologyObservationExample"> </a><a name="hcMorphologyObservationExample"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-nccp-morphology-observation.html">NCCP Morphology Observation</a></p></div><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs SHA-PATHOLOGY}">SHA: Pathology / Histopathology</span></p><p><b>subject</b>: <a href="Patient-example-patient.html">Mary Wanjiku Female, DoB: 1975-06-15</a></p><p><b>focus</b>: <a href="Condition-example-condition.html">Condition C50 — Malignant neoplasm of breast</a></p><p><b>effective</b>: 2025-11-10</p><p><b>performer</b>: <a href="Practitioner-example-practitioner.html">Practitioner James Otieno </a></p><p><b>value</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/morphology-codes-cs INVASIVE-DUCTAL-CARCINOMA}">Invasive Ductal Carcinoma</span></p><p><b>bodySite</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs BREAST}">Breast</span></p><p><b>method</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/morphology-method-cs BIOPSY}">Biopsy</span></p></div>
</text>
<status value="final"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/observation-category"/>
<code value="laboratory"/>
<display value="Laboratory"/>
</coding>
</category>
<code>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs"/>
<code value="SHA-PATHOLOGY"/>
<display value="SHA: Pathology / Histopathology"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/example-patient"/>
</subject>
<focus>🔗
<reference value="Condition/example-condition"/>
</focus>
<effectiveDateTime value="2025-11-10"/>
<performer>🔗
<reference value="Practitioner/example-practitioner"/>
</performer>
<valueCodeableConcept>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/morphology-codes-cs"/>
<code value="INVASIVE-DUCTAL-CARCINOMA"/>
<display value="Invasive Ductal Carcinoma"/>
</coding>
</valueCodeableConcept>
<bodySite>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs"/>
<code value="BREAST"/>
<display value="Breast"/>
</coding>
</bodySite>
<method>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/morphology-method-cs"/>
<code value="BIOPSY"/>
<display value="Biopsy"/>
</coding>
</method>
</Observation>